Related Experiment Video
Updated: Jun 24, 2026
07:30
A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
Autoimmune autonomic ganglionopathy
Frontiers of Neurology and Neuroscience
|April 8, 2009
Summary
Autoimmune autonomic ganglionopathy is an acquired disorder affecting the nervous system, characterized by antibodies to the nicotinic acetylcholine receptor. It causes gastrointestinal issues, orthostatic hypotension, and pupil abnormalities.
Area of Science:
- Neurology
- Immunology
- Autonomic Neuroscience
Background:
- Autoimmune autonomic ganglionopathy (AAG) is an idiopathic disorder impacting the autonomic nervous system.
- It is linked to antibodies targeting the ganglionic nicotinic acetylcholine receptor in various ganglia.
- Symptoms arise from widespread autonomic dysfunction.
Purpose of the Study:
- To describe the clinical features, course, and management of autoimmune autonomic ganglionopathy.
- To highlight the role of antibodies against the ganglionic nicotinic acetylcholine receptor.
Main Methods:
- Clinical case description and literature review.
- Identification of antibodies to ganglionic nicotinic acetylcholine receptor.
- Assessment of autonomic function and patient outcomes.
Main Results:
- Prominent symptoms include gastrointestinal dysmotility, orthostatic hypotension, and tonic pupils.
- Onset is typically subacute (less than 3 months), often monophasic with potential for partial recovery.
- Some cases exhibit a slowly progressive course mimicking degenerative autonomic failure.
Conclusions:
- Autoimmune autonomic ganglionopathy is an autoimmune disorder caused by antibodies against ion channels.
- Management involves supportive care for mild cases and immunomodulatory therapies for severe cases.
- Further research is needed to understand the pathogenesis and optimize treatment strategies.
Related Concept Videos
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:28Drugs Acting on Autonomic Ganglia: Blockers
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
01:18Disorders of the Autonomic Nervous System
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Raynaud's disease, also known as Raynaud's phenomenon, is a...
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:26Autonomic Nervous System: Overview
The human nervous system is divided into two main parts: the central nervous system (CNS) and the peripheral nervous system (PNS). The CNS is composed of the brain and spinal cord, while the PNS contains nerve cells, clusters of nerve cells, and the sensory receptors that are outside the CNS. The PNS has two types of nerve cells: sensory (afferent) and motor (efferent). Sensory cells send signals to the CNS from receptors, and motor cells carry signals from the CNS to organs, muscles, and...